Moderna, Inc.: Moderna Announces Advances Across mRNA Pipeline and Provides Business Update
COVID-19 vaccine sales for 2022 approximately $18.4 billion (unaudited)Reiterating 2023 expected minimum COVID-19 vaccine sales of approximately $5.0 billion; continue to expect additional contracts for
Source: finanznachrichten.de